Canada markets closed

Ovid Therapeutics Inc (1OT.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
2.7200-0.0200 (-0.73%)
At close: 08:05AM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-68,664
-52,339
-54,169
122,835
-81,036
-
Depreciation & amortization
998.606
1,597
1,382
237.079
306.848
-
Stock based compensation
6,142
7,285
6,557
5,054
7,525
-
Change in working capital
-2,836
2,386
-8,231
-16,814
21,819
-
Accounts Payable
-2,108
1,750
-5,174
1,702
2,334
-
Other working capital
-59,568
-45,918
-56,646
118,422
-51,975
-
Other non-cash items
-3,490
-2,706
-1,220
7,300
-199.408
-
Net cash provided by operating activites
-58,050
-45,781
-55,227
118,612
-51,584
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,518
-137.455
-1,419
-189.408
-390.68
-
Acquisitions, net
-2,500
-10,000
-2,500
-1,632
0
-
Purchases of investments
-108,858
-112,443
-172,964
0
-9,961
-
Sales/Maturities of investments
30,000
120,000
90,000
0
45,000
-
Other investing activites
-
-
-1,000
-
-
-
Net cash used for investing activites
-83,876
-2,581
-87,883
-1,821
34,648
-
Cash flows from financing activities
Common stock issued
-
-
-
0
46,731
86,407
Other financing activites
-
30,000
-
-21.314
-163.25
-
Net cash used privided by (used for) financing activities
333.437
30,535
180.658
904.082
47,072
-
Net change in cash
-141,592
-17,826
-142,930
117,694
30,137
-
Cash at beginning of period
201,780
46,799
189,728
72,034
41,897
-
Cash at end of period
60,187
28,972
46,799
189,728
72,034
-
Free Cash Flow
Operating Cash Flow
-58,050
-45,781
-55,227
118,612
-51,584
-
Capital Expenditure
-1,518
-137.455
-1,419
-189.408
-390.68
-
Free Cash Flow
-59,568
-45,918
-56,646
118,422
-51,975
-